Does negative calcium score exclude coronary artery disease  by Al Helali, Sumaya et al.
Atrioventricular septal defect cases 7 cases (12%), the
arterial switch cases 6 cases (11%), and others 8 cases
(14%). The ICU stay, the length of hospital stay and the
bypass time were significantly longer in the chylothorax
group, also the ventilation time, the inotropes duration
and number were higher in the chylothorax group.
Conclusion: Chylothorax after pediatric open heart
surgery is not an uncommon complication, it occurs more
commonly with single ventricle repair and aortic arch
repair surgeries, it has a significant impact on the post
operative course and post operative morbidity.
http://dx.doi:10.1016/j.jsha.2012.06.255
Is there an optimal intensive care management?
Following release of obstruction in neonates with
critical PS/ATR & IVS
Shawana Farooq Shaikh
Neonates with critical pulmonary stenosis or
complete pulmonary artesia and intact interventric-
ular septum represent wide range of pathological
findings in term of magnitude of hypoplasia of
the different right ventricular components.
Although available range of imaging modalities
enabled paediatric cardiologist to delineate, who
would benefit from interventional or surgical
release of critical pulmonary stenosis/atresia. The
post interventional or and after surgical release of
critical pulmonary stenosis/atresia challenges the
paediatric cardiac intensivist with various spectrum
of pathophysiological status.
Empirically we noticed that some neonates
recover and discharged from the intensive care unit
in 2–3 days, while others require longer intensive
care management and quite good number will stay
in the ICU much longer on prostaglandin infusion
and may require further intervention such as bal-
loon atrial septostomy, shunt or implantation of
PDA stent.
We have retrospectively evaluated these patients
in relation to pre and post operative/interventional
pathology/pathophysiology, age and general status
of patients before and after procedures and high-
lighting the intensive care physical and pharmaco-
logical actions.
http://dx.doi:10.1016/j.jsha.2012.06.256
Comparison of femoral closure devices with man-
ual compression in postcardiac catheterization
patients
Sulman Razzaq, Paul S. Gilmore, Robert F. Percy
Objective: The objective of our study was to com-
pare femoral closure devices to manual compression in
limiting vascular access complications at our center.
Methods: Data was obtained from computer data-
base for cardiac catheterizations done at University of
Florida, Jacksonville from 1st March 2002 to 29th Febru-
ary 2004. Vascular complications included groin bleeding,
hematoma (> 4 cm), retroperitoneal bleeding, AV fistula,
limb ischemia , pseudoaneurysm, infection and death
as a direct result of vascular complication. Hemostasis
technique was divided into three groups; Manual com-
pression, Sealant and Suture group.
Results: A total number of 3843 cases were per-
formed and all variables were similarly distributed
among three groups except for lesser GpIIb/IIIa inhibitor
use in sealant group. A total of 71 complications (1.85%)
were recorded. They included 33 bleeds, 12 Pseudoaneu-
rysms, 17 hematomas (> 4 cm), 4 retroperitoneal bleeds, 2
AV fistulae, 1 infection and 2 deaths. Overall, 9 complica-
tions occurred in Sealant group (0.85%), 4 in Suture
group (3.3%) and 58 (2.1%) in manual compression.
Logistic regression analysis showed that when GpIIb/IIIa
agents are not used, Sealant device is associated with less
vascular complications. (p = 0.008) However, with GpIIb/
IIIa agents there is no difference among closure devices
or manual compression (p = 0.074) with overall increase
in vascular complications.
Conclusions: Sealant closure devices are associated
with less vascular complications at our center when
GpIIb/IIIa agents were not used. However, with GPIIb/
IIIa inhibitors , there is no difference in the vascular com-
plications among the three groups.
http://dx.doi:10.1016/j.jsha.2012.06.257
Does negative calcium score exclude coronary
artery disease
Sumaya Al Helali, Mohammed Al Mehari, Kazem
Hameedullah, Samer Al Dulikan, Abdullah
Bafagih, Saeed Al Ahmari
Aim: We aimed to measure the coronary calcification
and investigate if negative coronary calcification excludes
coronary artery disease (CAD).
Methods: Clinically indicated patients were scanned
using 64 slice CCT to measure Agatston coronary calcifi-
cation score. CT coronary angiography( CTA) was per-
formed, and invasive coronary angiography (CA) was
performed when it is indicated.
Results: 2352 patients were scanned. 1152 patients
had negative calcium score (49%). The mean age was
52 ± 13.2 y, 65% males, & 35% females. Chest pain was
the indication in 80% of cases. There was 37% diabetic,
58% hypertensive, 23.6% hyperlipidemic, 13% smoker,
& 32% with family history of CAD.
The calcium score excludes CAD in 90% of patients as
confirmed by normal coronary CTA. In 10% of patients
who had negative calcium, coronary plaques were found
by CTA. CA was performed in 50% of those with negative
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CA score, where 30% had coronary stenting, 20% had
bypass surgery , 35% had mild disease, and 15% had
non obstructive lesions.
Conclusion: Negative calcium score excludes CAD
in 90% of patients as confirmed by normal CTA. Coro-
nary CTA is an important tool to detect early coronary
atherosclerosis even in absence of coronary calcification.
http://dx.doi:10.1016/j.jsha.2012.06.258
Effect of intracoronary (IC) transplantation of
autologous bone marrow-derived mesenchymal
stem cells (BMSC) in patients with advanced left
ventricular systolic dysfunction
Tamer El Khayat, Wael Aboul Kheir, Gamal Aboul
Nasr
Background: In the absence of cardiac transplanta-
tion programs and high cost of CRT-ICD in our commu-
nity, large numbers of no-option HF patients (pts) for
revascularization are still markedly symptomatic. IC-
BMSC appears as promising option.
Methods: 33 (27 males) with chronic HF, LVEF 6 35
and mean age 46 y divided into 2 groups, 17 BMSC pts
and 16 pts control. Both were maintained on maximum
tolerated medications (follow-up 258 + 47 days). NYHA
function class (NYHAFC), six minutes walking test
(6MWT), LVESD, LVEDD, 2D-LVEF, systolic (S) and ear-
lydiastolic (E) mitral annulus velocities by TDI evaluated.
BMSC were obtained and selectively IC injected.
Results: Both groups showed improvement in
NYHAFC from 3 to 2, P < 0.001 in BMSC, P < 0.04 for con-
trol. 6MWT marginally improved in BMSC from 348 ± 91
to 406 ± 87 meters (m) P < 0.06 while no improvement was
noticed in control (361 ± 47 to 336 ± 110M, PNS). LVESD
Figure 1.
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